An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
type: MedicalStudy
description: An International, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of CORLUX™ (Mifepristone) vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Psychotic Major Depression (PMD)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2005-05
end date: 2006-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00146523
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Corcept Therapeutics
study subject: Major Depressive Disorder
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Major Depressive Disorder

AI Analytics
type: Organization